QUAD Investment Management
Seoulquadim.com
Overview
QUAD Investment Management is a South Korea-based investment firm that offers strategies including long/short equities, long-only, and private equity opportunities, with a focus on the healthcare and technology sectors.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Mediwhale | Mar 2026 | Series C | Co-investor |
| NEX-I, Inc. | Aug 2025 | Series B | Co-investor |
| Illimis Therapeutics | Jul 2025 | Series B | Co-investor |
| Prazer Therapeutics | Apr 2025 | Series B | Co-investor |
| HoneyNaps | May 2024 | Series B | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.